Congenital measles cases are emerging in newborn infants across the United States as national vaccination coverage continues to decline.
Health officials reported 13 congenital measles cases to the US Centers for Disease Control and Prevention between the start of 2025 and late September, according to IT BOLTWISE x Super Intelligence. The rare condition occurs when the virus passes from an infected pregnant woman to the fetus.
Medical professionals recorded 112 total cases of measles during pregnancy in the same timeframe. Almost all of those patients lacked a pre-pregnancy vaccination or had an unclear immunization record.
When community protection drops, transmission chains multiply and expose vulnerable populations to the virus. Lower overall coverage leaves pregnant women without immunity, which increases the likelihood of transplacental transmission.
The United States lost its measles-free status after experiencing its highest infection rates in more than 30 years. More than 7,500 measles cases occurred across the country in a two-year span, creating conditions where rare complications surface more frequently.
Only 92.4% of US kindergarteners received the required MMR vaccine during the 2025/2026 school year, according to CDC data. Public health guidelines typically require a 95% community coverage rate to prevent large outbreaks.
Routine measles, mumps, and rubella vaccinations usually start between 12 and 15 months of age. Health departments can lower the initial vaccination age to 6 months for infants living inside active outbreak zones.
Infected newborns can develop fever, jaundice, and a characteristic rash if exposure occurs late in pregnancy. Severe complications range from pneumonia to brain inflammation, alongside rare long-term risks such as subacute sclerosing panencephalitis.
Medical professionals recommend administering the MMR vaccine to women of childbearing age before pregnancy. This strategy protects the mother and transfers protective antibodies across the placenta to shield newborns during their earliest weeks.
Unvaccinated pregnant women who face virus exposure can receive an antibody treatment within six days to reduce infection risks. Healthcare providers continue monitoring whether infants born with congenital infections face an elevated risk of developing subacute sclerosing panencephalitis later in life.
Falling vaccination rates across the general population have fueled widespread outbreaks that create more opportunities for unprotected pregnant women to encounter the virus.
The MMR vaccine is not administered during pregnancy because it is a live-attenuated vaccine. Physicians instead focus on pre-pregnancy immunization and post-exposure antibody treatments.
The US Centers for Disease Control and Prevention began as the Communicable Disease Center on July 1, 1946, replacing a World War II malaria program with a staff of 369 and a budget of about $1 million. Its early work focused heavily on mosquito abatement, spraying more than six and a half million homes, mostly with DDT, to eradicate malaria in the United States.
In 1951, the Korean War prompted the creation of the Epidemic Intelligence Service, a postgraduate training program that later expanded into Field Epidemiology Training Programs operating in over 80 countries. The agency inherited the Tuskegee syphilis experiment from the U.S. Public Health Service, a study that continued until 1972.
Infants infected in utero can exhibit a measles rash, jaundice, and fever, while facing serious risks of pneumonia and neurological complications.
Worth a look
- Bacteria Turn Desert Sand Into Water-Retentive ‘Living Sand
- India’s Triple Burden of Malnutrition: Clinical Guidance on Supplements, Protein Risks, and Dietary Shifts
- Measles Detected In Stamford Wastewater: City Health Department (newsylist.com)
- Papal Health Disclosures Shape Illness Perceptions (archyde.com)